We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Warfarin Use Can Increase Dementia Risk in AF Patients

By HospiMedica International staff writers
Posted on 19 May 2016
Print article
Image: Warfarin may increase the risk of dementia in certain populations (Photo courtesy of Fotolia).
Image: Warfarin may increase the risk of dementia in certain populations (Photo courtesy of Fotolia).
A new study shows that atrial fibrillation (AF) patients treated over a long period of time with Warfarin experience higher rates of dementia than their counterparts.

Researchers at Intermountain Medical Center (IMC; Salt Lake City, UT, USA) enrolled 10,537 patients with no prior history of dementia who were treated with warfarin for both AF and other, non-AF conditions (such as valvular heart disease and thromboembolism) on a long-term basis. The researchers also examined other variables, such as age, hypertension, diabetes, hyperlipidemia, renal failure, smoking history, prior myocardial infarction (MI) or cerebral vascular accident, and heart failure. Participants were aged 18 years and older.

The results showed that during a follow-up of approximately seven years, dementia was more prevalent in the AF group (5.8%) than the non-AF group (1.6%). In both groups the risk of dementia increased as time in therapeutic range decreased, or became erratic; when warfarin levels were consistently too high or too low, dementia rates increased. Regardless of the adequacy of anticoagulation, the AF patients consistently experienced higher rates of all forms of dementia. The study was presented at the 37th annual scientific sessions of the Heart Rhythm Society, held during May 2016 in San Francisco (CA, USA).

“As physicians we have to understand that although we need to use anticoagulants for many reasons, including to prevent stroke in AF patients, at that same time there are risks that need to be considered, some of which we are only right now beginning to understand,” said lead author T. Jared Bunch, MD, director of heart rhythm research at IMC. “In this regard, only those that absolutely need blood thinners should be placed on them long-term. In people that are on warfarin in which the levels are erratic or difficult to control, switching to newer agents that are more predictable may lower risk.”

Warfarin decrease blood coagulation by inhibiting vitamin K epoxide reductase, an enzyme that recycles oxidized vitamin K to its reduced form after it has participated in the carboxylation of several blood coagulation proteins, mainly prothrombin and factor VII. It was initially introduced in 1948 as a pesticide against rats and mice and is still popular for this purpose. In the early 1950's warfarin was found to be effective and relatively safe for preventing thrombosis and embolism in many disorders. It is the most widely prescribed oral anticoagulant drug in North America.

Related Links:
Intermountain Medical Center
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Vibrating Mesh Nebulizer
Aerogen Solo

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.